Published in Nat Med on January 15, 2012
In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease. Nat Med (2014) 2.54
Targeted imaging of esophageal neoplasia with a fluorescently labeled peptide: first-in-human results. Sci Transl Med (2013) 2.30
A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis. Cancer Cell (2017) 1.39
Screening for oesophageal cancer. Nat Rev Clin Oncol (2012) 1.13
Mapping posttranscriptional regulation of the human glycome uncovers microRNA defining the glycocode. Proc Natl Acad Sci U S A (2014) 0.95
Imaging cell surface glycosylation in vivo using "double click" chemistry. Bioconjug Chem (2013) 0.94
Rapid ratiometric biomarker detection with topically applied SERS nanoparticles. Technology (Singap World Sci) (2014) 0.93
Method for assessing the reliability of molecular diagnostics based on multiplexed SERS-coded nanoparticles. PLoS One (2013) 0.92
In vivo molecular imaging of Barrett's esophagus with confocal laser endomicroscopy. Gastroenterology (2013) 0.91
Optical imaging of periostin enables early endoscopic detection and characterization of esophageal cancer in mice. Gastroenterology (2012) 0.91
Biomarkers for dysplastic Barrett's: ready for prime time? World J Surg (2015) 0.89
Optical molecular imaging in the gastrointestinal tract. Gastrointest Endosc Clin N Am (2013) 0.89
Molecular imaging in gastroenterology. Nat Rev Gastroenterol Hepatol (2013) 0.89
Emerging optical methods for surveillance of Barrett's oesophagus. Gut (2015) 0.88
Color-matched and fluorescence-labeled esophagus phantom and its applications. J Biomed Opt (2013) 0.87
Multispectral endoscopic imaging of colorectal dysplasia in vivo. Gastroenterology (2012) 0.86
Comprehensive spectral endoscopy of topically applied SERS nanoparticles in the rat esophagus. Biomed Opt Express (2014) 0.86
Serum Glycoprotein Biomarker Discovery and Qualification Pipeline Reveals Novel Diagnostic Biomarker Candidates for Esophageal Adenocarcinoma. Mol Cell Proteomics (2015) 0.85
Advances in lectin microarray technology: optimized protocols for piezoelectric print conditions. Curr Protoc Chem Biol (2013) 0.85
State of the art in advanced endoscopic imaging for the detection and evaluation of dysplasia and early cancer of the gastrointestinal tract. Clin Exp Gastroenterol (2014) 0.85
Dot by dot: analyzing the glycome using lectin microarrays. Curr Opin Chem Biol (2013) 0.84
Intravital Fluorescence Excitation in Whole-Animal Optical Imaging. PLoS One (2016) 0.84
In vivo multiplexed molecular imaging of esophageal cancer via spectral endoscopy of topically applied SERS nanoparticles. Biomed Opt Express (2015) 0.84
EGFR Overexpressed in Colonic Neoplasia Can be Detected on Wide-Field Endoscopic Imaging. Clin Transl Gastroenterol (2015) 0.84
Barrett's esophagus: A review of diagnostic criteria, clinical surveillance practices and new developments. J Gastrointest Oncol (2012) 0.83
Studying the effects of reproductive hormones and bacterial vaginosis on the glycome of lavage samples from the cervicovaginal cavity. PLoS One (2015) 0.82
Indications, stains and techniques in chromoendoscopy. QJM (2012) 0.82
Research advances in esophageal diseases: bench to bedside. F1000Prime Rep (2013) 0.82
Molecular markers and imaging tools to identify malignant potential in Barrett's esophagus. World J Gastrointest Pathophysiol (2014) 0.81
Molecular imaging in endoscopy. United European Gastroenterol J (2013) 0.80
Intraoperative targeted optical imaging: a guide towards tumor-free margins in cancer surgery. Curr Pharm Biotechnol (2013) 0.80
Wireless fluorescence capsule for endoscopy using single photon-based detection. Sci Rep (2015) 0.80
The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities. Adv Cancer Res (2015) 0.79
Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging. Angew Chem Int Ed Engl (2015) 0.78
Biophotonic endoscopy: a review of clinical research techniques for optical imaging and sensing of early gastrointestinal cancer. Endosc Int Open (2015) 0.78
In vivo fluorescence microscopy: lessons from observing cell behavior in their native environment. Physiology (Bethesda) (2015) 0.77
Role of endoscopy in early oesophageal cancer. Nat Rev Gastroenterol Hepatol (2016) 0.77
Surgical Guidance via Multiplexed Molecular Imaging of Fresh Tissues Labeled with SERS-Coded Nanoparticles. IEEE J Sel Top Quantum Electron (2016) 0.77
Label-free multi-photon imaging of dysplasia in Barrett's esophagus. Biomed Opt Express (2015) 0.77
Endoscopic molecular imaging: status and future perspective. Clin Endosc (2013) 0.77
Barrett's esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther (2016) 0.76
Design and Synthesis of Near-Infrared Peptide for in Vivo Molecular Imaging of HER2. Bioconjug Chem (2015) 0.76
Synthesis and characterization of anti-EGFR fluorescent nanoparticles for optical molecular imaging. Bioconjug Chem (2013) 0.76
Imaging Tumor Metabolism to Assess Disease Progression and Treatment Response. Clin Cancer Res (2016) 0.75
A guide to multimodal endoscopy imaging for gastrointestinal malignancy - an early indicator. Nat Rev Gastroenterol Hepatol (2017) 0.75
Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma. Br J Cancer (2016) 0.75
Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas. Oncotarget (2016) 0.75
The use of optical imaging techniques in the gastrointestinal tract. Frontline Gastroenterol (2015) 0.75
A standardized method for lectin microarray-based tissue glycome mapping. Sci Rep (2017) 0.75
Molecular imaging of oral premalignant and malignant lesions using fluorescently labeled lectins. Transl Oncol (2014) 0.75
Detection of colorectal dysplasia using fluorescently labelled lectins. Sci Rep (2016) 0.75
Beyond Dysplasia Grade: The Role of Biomarkers in Stratifying Risk. Gastrointest Endosc Clin N Am (2017) 0.75
TGM2: a cell surface marker in esophageal adenocarcinomas. J Thorac Oncol (2014) 0.75
Imaging Glycosylation In Vivo by Metabolic Labeling and Magnetic Resonance Imaging. Angew Chem Weinheim Bergstr Ger (2015) 0.75
Light in diagnosis, therapy and surgery. Nat Biomed Eng (2017) 0.75
Endoscopic modalities for the diagnosis of Barrett's oesophagus. United European Gastroenterol J (2015) 0.75
Enhanced Reality and Intraoperative Imaging in Colorectal Surgery. Clin Colon Rectal Surg (2015) 0.75
Toward real-time quantification of fluorescence molecular probes using target/background ratio for guiding biopsy and endoscopic therapy of esophageal neoplasia. J Med Imaging (Bellingham) (2017) 0.75
Management controversies in Barrett's oesophagus. J Gastroenterol (2013) 0.75
Plant Lectins as Medical Tools against Digestive System Cancers. Int J Mol Sci (2017) 0.75
Esophageal cancer. N Engl J Med (2003) 15.23
Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med (2009) 10.91
The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer (2005) 5.98
Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat Med (2008) 4.83
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer (2010) 3.27
Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol (2000) 2.99
Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling. Nat Methods (2005) 2.66
Imaging the glycome. Proc Natl Acad Sci U S A (2008) 2.62
Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol (2000) 2.58
Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N Engl J Med (1992) 2.52
Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer (2009) 2.33
Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography. Gastrointest Endosc (2006) 2.31
Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Gut (2008) 2.20
Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology (1988) 2.06
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology (2010) 2.05
Affinity peptide for targeted detection of dysplasia in Barrett's esophagus. Gastroenterology (2010) 1.93
Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science (1981) 1.88
Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett's oesophagus. Gut (2006) 1.78
Multispectral scanning during endoscopy guides biopsy of dysplasia in Barrett's esophagus. Nat Med (2010) 1.76
Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin. Nature (1982) 1.48
A ratiometric lectin microarray approach to analysis of the dynamic mammalian glycome. Proc Natl Acad Sci U S A (2007) 1.44
A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. Gastroenterology (2010) 1.43
In situ detection of nuclear atypia in Barrett's esophagus by using angle-resolved low-coherence interferometry. Gastrointest Endosc (2007) 1.34
Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett's oesophagus. J Pathol (2003) 1.31
The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. Adv Drug Deliv Rev (2004) 1.30
Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging. Cancer Res (2009) 1.28
Endoscopic trimodal imaging versus standard video endoscopy for detection of early Barrett's neoplasia: a multicenter, randomized, crossover study in general practice. Gastrointest Endosc (2010) 1.27
Wheat germ agglutinin. Isolation and crystallization. J Biol Chem (1972) 1.19
Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. Cancer Res (2001) 1.18
Application of a macromolecular contrast agent for detection of alterations of tumor vessel permeability induced by radiation. Clin Cancer Res (2004) 1.04
Specificity of isolectins of wheat germ agglutinin for sialyloligosaccharides: a 360-MHz proton nuclear magnetic resonance binding study. Biochemistry (1982) 0.97
Regulation of sialic acid O-acetylation in human colon mucosa. Biol Chem (2004) 0.85
Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat Med (2007) 6.84
Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet (2006) 5.83
Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate. Nature (2008) 5.60
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut (2013) 4.29
A clamping mechanism involved in SNARE-dependent exocytosis. Science (2006) 3.74
Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. BMJ (2010) 3.44
Energetics and dynamics of SNAREpin folding across lipid bilayers. Nat Struct Mol Biol (2007) 3.39
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J (2011) 2.97
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
13C MR spectroscopy measurements of glutaminase activity in human hepatocellular carcinoma cells using hyperpolarized 13C-labeled glutamine. Magn Reson Med (2008) 2.34
miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell (2011) 2.30
Alternative zippering as an on-off switch for SNARE-mediated fusion. Science (2009) 2.30
Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res (2003) 2.24
Analyzing the dynamic bacterial glycome with a lectin microarray approach. Nat Chem Biol (2006) 2.19
Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. J Hepatol (2010) 2.18
Regulation of membrane fusion by the membrane-proximal coil of the t-SNARE during zippering of SNAREpins. J Cell Biol (2002) 2.13
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology (2010) 2.05
Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors. Proc Natl Acad Sci U S A (2009) 2.04
The β-adrenoceptor agonist isoproterenol rescues acetaminophen-injured livers through increasing progenitor numbers by Wnt in mice. Hepatology (2014) 2.03
Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol (2003) 1.95
The use of immunoglobulin g4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis. Clin Gastroenterol Hepatol (2007) 1.83
Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. Gastroenterology (2013) 1.77
Barrett's metaplasia glands are clonal, contain multiple stem cells and share a common squamous progenitor. Gut (2011) 1.77
Kinetic modeling of hyperpolarized 13C label exchange between pyruvate and lactate in tumor cells. J Biol Chem (2011) 1.76
Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol (2007) 1.75
Retinoic acid-induced glandular differentiation of the oesophagus. Gut (2006) 1.75
Magnetization transfer measurements of exchange between hyperpolarized [1-13C]pyruvate and [1-13C]lactate in a murine lymphoma. Magn Reson Med (2010) 1.74
Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol (2009) 1.70
A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet (2013) 1.67
Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1- 13C]pyruvate and 13C magnetic resonance spectroscopic imaging. Magn Reson Med (2010) 1.65
Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol (2005) 1.65
Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. Gastroenterology (2002) 1.63
Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease. Am J Gastroenterol (2009) 1.62
Distinct domains of complexins bind SNARE complexes and clamp fusion in vitro. J Biol Chem (2008) 1.59
Development of a lectin microarray for the rapid analysis of protein glycopatterns. Chembiochem (2005) 1.55
Clinical proton MR spectroscopy in central nervous system disorders. Radiology (2014) 1.53
Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus. Gastrointest Endosc (2012) 1.53
A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment. Neoplasia (2009) 1.52
Proton NMR analysis of plasma is a weak predictor of coronary artery disease. Nat Med (2006) 1.49
Hyperpolarized [1-13C]-ascorbic and dehydroascorbic acid: vitamin C as a probe for imaging redox status in vivo. J Am Chem Soc (2011) 1.47
A ratiometric lectin microarray approach to analysis of the dynamic mammalian glycome. Proc Natl Acad Sci U S A (2007) 1.44
A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. Gastroenterology (2010) 1.43
In vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma. Cancer Res (2006) 1.41
Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers. Proc Natl Acad Sci U S A (2010) 1.41
Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia. J Exp Med (2013) 1.40
HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin. Nat Chem Biol (2009) 1.40
Countercurrent distribution of two distinct SNARE complexes mediating transport within the Golgi stack. Mol Biol Cell (2004) 1.39
Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus. Gastroenterology (2012) 1.37
Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index. Eur J Radiol (2011) 1.35
Elastic scattering spectroscopy for the diagnosis of colonic lesions: initial results of a novel optical biopsy technique. Gastrointest Endosc (2006) 1.31
Assessing responses to cancer therapy using molecular imaging. Biochim Biophys Acta (2006) 1.31
Localization and activity of the SNARE Ykt6 determined by its regulatory domain and palmitoylation. Proc Natl Acad Sci U S A (2004) 1.28
Ym1 is a neutrophil granule protein that crystallizes in p47phox-deficient mice. J Biol Chem (2001) 1.28
Uric acid promotes tumor immune rejection. Cancer Res (2004) 1.26
Surface expression of minichromosome maintenance proteins provides a novel method for detecting patients at risk for developing adenocarcinoma in Barrett's esophagus. Clin Cancer Res (2003) 1.26
Evaluation of predicted network modules in yeast metabolism using NMR-based metabolite profiling. Genome Res (2007) 1.26
Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms. Gastroenterology (2007) 1.23
Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology (2009) 1.22
A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Semin Cancer Biol (2013) 1.21
1H MRS-visible lipids accumulate during apoptosis of lymphoma cells in vitro and in vivo. Magn Reson Med (2005) 1.20
Artifactual uncoupling by uncoupling protein 3 in yeast mitochondria at the concentrations found in mouse and rat skeletal-muscle mitochondria. Biochem J (2002) 1.19
Mitochondrial dysfunction in patients with primary congenital insulin resistance. J Clin Invest (2011) 1.19
A simple strategy for the creation of a recombinant lectin microarray. Mol Biosyst (2008) 1.16
A lectin microarray approach for the rapid analysis of bacterial glycans. Nat Protoc (2006) 1.16
Identification of a conserved glycan signature for microvesicles. J Proteome Res (2011) 1.14
Detection of tumor response to a vascular disrupting agent by hyperpolarized 13C magnetic resonance spectroscopy. Mol Cancer Ther (2010) 1.14
i-SNAREs: inhibitory SNAREs that fine-tune the specificity of membrane fusion. J Cell Biol (2003) 1.14
Screening for oesophageal cancer. Nat Rev Clin Oncol (2012) 1.13
Population-based study reveals new risk-stratification biomarker panel for Barrett's esophagus. Gastroenterology (2012) 1.13
Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice. Hepatology (2013) 1.13
Gastric IgG4-Related Autoimmune Fibrosclerosing Pseudotumour: A Novel Location. ISRN Gastroenterol (2010) 1.12
Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis. Clin Cancer Res (2004) 1.12
Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations. Am J Gastroenterol (2013) 1.12
Use of multivariate analysis to suggest a new molecular classification of colorectal cancer. J Pathol (2013) 1.09
Deciphering the glycocode: the complexity and analytical challenge of glycomics. Curr Opin Chem Biol (2007) 1.09
Imaging pH with hyperpolarized 13C. NMR Biomed (2011) 1.08
Cross-platform comparison of glycan microarray formats. Glycobiology (2014) 1.08
Development and evaluation of new cyclooctynes for cell surface glycan imaging in cancer cells. Chem Sci (2011) 1.08
Hyperpolarized (13)C spectroscopy detects early changes in tumor vasculature and metabolism after VEGF neutralization. Cancer Res (2012) 1.07
Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma. J Clin Oncol (2013) 1.06
Detection of tumor glutamate metabolism in vivo using (13)C magnetic resonance spectroscopy and hyperpolarized [1-(13)C]glutamate. Magn Reson Med (2011) 1.06
Genetic predisposition to gastro-oesophageal cancer. Curr Opin Genet Dev (2010) 1.06
A systematic approach to therapeutic target selection in oesophago-gastric cancer. Gut (2012) 1.05